Australia's Therapeutic Goods Administration has approved a new COVID booster by Pfizer targeting the JN.1 sub-variant of Omicron. Despite evolving variants, boosters remain crucial, especially for ...

So an annual COVID booster is not considered enough for some more vulnerable people. For adults aged 65 to 74, a booster is ...

While KP.3.1.1. remains the predominant COVID-19 variant in the United States, the XEC variant has taken the No. 2 spot — and is on the rise. XEC has mutations that make it highly contagious ...